We are proud to announce that TissueTech, Amniox, and Bio-Tissue will now be known under a single commercial, customer-facing entity – BioTissue.
As one unified brand with one platform technology behind it,
our vision has become even clearer:
Realize the full potential of regenerative therapy.
We are BioTissue. The most human form of healing.
Read the Full Details HereBio-Tissue provides innovative wound healing solutions through a comprehensive line of ocular surface products – PROKERA®, AmnioGraft® and AmnioGuard®.
Eye care professionals understand that good medicine is based on good science. Bio-Tissue prides itself on developing products that meet the highest clinical standards, are based on quality research and scientific data and provide innovative solutions for a range of ocular surface and lid margin diseases.
Using PROKERA on the eye reduces scar formation and controls inflammation. It also supports reepithelialization due to the various ocular surface diseases.
We believe in utilizing the natural properties of human amniotic membrane tissue to promote wound healing.
We are proud to announce that we are a Donate Life℠ Partner! We kicked off our partnership by celebrating Donate Life National Blue and Green Day last Friday, April 16th, in honor of those who have helped heal lives through the gift of tissue donation. We will be working with Donate Life America to raise public awareness about the importance of tissue donation to increase tissue donor registration.
Bio-Tissue® proprietary CryoTek® cryopreservation process is the result of more than 30 years of research studying the biology of the Amniotic Membrane and Umbilical Cord. The CryoTek method ensures the retention of crucial healing components of the Extracellular Matrix (ECM),1,2,3 which uniquely promotes regenerative healing.
Sources:
1 Rinastiti M, et al. Int J Oral Maxillofac Surg. 2006; 35:247-251.
2 Jin CZ, et al. Tissue Eng. 2007; 13:693-702.
3 Niknejad H, et al. Eur Cell Mater. 2008; 15:88-99.
Bio-Tissue prides itself on developing products that meet the highest clinical standards, are based on quality research and scientific data, and provide innovative solutions for a range of ocular surface and eyelid margin diseases. Bio-Tissue adheres to all FDA tissue and medical device guidelines, and additionally, meets all regulatory standards for the American Association of Tissue Banks (AATB).
TissueTech’s proprietary flagship CryoTek® process utilizes freezing to preserve the functional and structural integrity of the tissues while maintaining their natural hydrated state. Other forms of processing that require dehydration of the matrix have been shown to degrade the critical biological properties, and may limit the tissue’s capabilities.
Contact Us
Physician Portal
